Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-Moderate Alzheimer's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01696123
What this trial is testing

Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine

Who this might be right for
Alzheimer Disease
Shahid Beheshti University of Medical Sciences 125
Early research (Phase 1)Study completedNCT02820896
What this trial is testing

RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01436045
What this trial is testing

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

Who this might be right for
Alzheimer's Disease
HealthPartners Institute 12
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00749216
What this trial is testing

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 33
Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Not applicableAvailableNCT03539380
What this trial is testing

TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
TauRx Therapeutics Ltd
Testing effectiveness (Phase 2)Study completedNCT04251182
What this trial is testing

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

Who this might be right for
Alzheimer Disease
T3D Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT03001557
What this trial is testing

Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia

Who this might be right for
Irregular Sleep-Wake Rhythm Disorder
Eisai Inc. 63
Post-approval studies (Phase 4)Ended earlyNCT01181921
What this trial is testing

The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen-Cilag, S.A. 1
Not applicableEnded earlyNCT02249468
What this trial is testing

An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population

Who this might be right for
Mild and Moderate Alzheimer's DiseaseCognitively Healthy People
Danone Nutricia Research 191
Large-scale testing (Phase 3)Study completedNCT00838110
What this trial is testing

Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 742
Not applicableStudy completedNCT06151808
What this trial is testing

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 42
Early research (Phase 1)Study completedNCT00965588
What this trial is testing

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 19
Not applicableEnded earlyNCT03672474
What this trial is testing

REGEnLIFE RGn530 - Feasibility Pilot

Who this might be right for
Alzheimer Disease
University Hospital, Montpellier 60
Early research (Phase 1)Study completedNCT04040348
What this trial is testing

Alzheimer's Disease Stem Cells Multiple Infusions

Who this might be right for
Alzheimer Disease
Bernard (Barry) Baumel 6
Large-scale testing (Phase 3)Looking for participantsNCT06534723
What this trial is testing

Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Who this might be right for
Alzheimer's Dementia
Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT05189210
What this trial is testing

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Mild to Moderate Alzheimer's Disease
GemVax & Kael 199
Early research (Phase 1)Study completedNCT01369225
What this trial is testing

Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 52
Not applicableUnknownNCT05114499
What this trial is testing

Efficacy and Safety of Donepezil and Sodium Oligomannate in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
First Affiliated Hospital Xi'an Jiaotong University 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation